vitro, yet its in vivo metabolic impact remains elusive. Wild type (WT) and transgenic (Tg) mice overexpressing human MR were subjected to standard chow (SC) or high-fat diet (HFD) for 16 wk. Tg mice had a lower body weight gain than WT animals and exhibited a relative resistance to HFD-induced obesity. This was associated with a decrease in fat mass, an increased population of smaller adipocytes, and an improved glucose tolerance compared with WT animals. Quantitative RT-PCR studies revealed decreased expression of PPAR␥2, a master adipogenic gene, and of glucocorticoid receptor and 11␤-hydroxysteroid dehydrogenase type 1, consistent with an impaired local glucocorticoid signaling in adipose tissues (AT). This paradoxical resistance to HFD-induced obesity was not related to an adipogenesis defect since differentiation capacity of Tg preadipocytes isolated from stroma-vascular fractions was unaltered, suggesting that other nonadipocyte factors might compromise AT development. Although AT macrophage infiltration was not different between genotypes, Tg mice exhibited a distinct macrophage polarization, as revealed by FACS analysis and CD11c/CD206 expression studies. We further demonstrated that Tg macrophage-conditioned medium partially impaired preadipocyte differentiation. Therefore, we propose that modification of M1/M2 polarization of hMR-overexpressing macrophages could account in part for the metabolic phenotype of Tg mice. Collectively, our results provide evidence that MR exerts a pivotal immunometabolic role by controlling adipocyte differentiation processes directly but also indirectly through macrophage polarization regulation. Our findings should be taken into account for the pharmacological treatment of metabolic disorders. adipocyte; glucocorticoid signaling; energy homeostasis; immunometabolism; mineralocorticoid receptor THE OBESITY PANDEMIC OF OUR INDUSTRIALIZED COUNTRIES is related to dramatic changes in nutritional and physical activities over the last decades. More recently, it was reported that obesity is a proinflammatory state characterized by adipose tissue (AT) inflammation, including AT infiltration by macrophages and lymphocytes, and local and systemic overproduction of cytokines, chemokines, and prothrombotic factors (3, 11, 16, 25, 27, 35, 36, 63, 64, 72, 73) . There is likely a causal relationship between the obesity-associated remodeling of AT and the development of insulin resistance, type 2 diabetes, and cardiovascular diseases (14, 36, 74) . Conversely, weight loss in obese patients decreases the magnitude of AT inflammation (7, 12, 15, 21, 62, 68a).
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The mineralocorticoid receptor (MR), a steroid receptor belonging to the nuclear receptor superfamily of transcription factors, plays a key role in hydroelectrolytic homeostasis in epithelial tissues such as kidney and colon. Because of similar affinity of the MR for aldosterone and cortisol (1, 24) , the tissue selectivity of aldosterone effects is ensured by the presence of the 11␤-hydroxysteroid dehydrogenase type 2 (11HSD2), an enzyme that converts cortisol (corticosterone in rodents) into its inactive metabolites that are unable to bind MR (30) . By contrast, in nonepithelial tissues lacking 11HSD2, and because plasma glucocorticoid concentration is 100 -1,000 times higher than that of aldosterone, it is generally considered that glucocorticoids are the physiological MR ligands (70) . Moreover, in AT, the local effect of glucocorticoids is even reinforced by the high local expression of 11␤-hydroxysteroid dehydrogenase type 1 (11HSD1) that regenerates active cortisol (corticosterone in rodents) from its inactive metabolites (19, 54) .
Similarities between the metabolic syndrome (MetS) and the phenotype observed in patients with glucocorticoid excess (Cushing's syndrome) have suggested that altered corticosteroid AT metabolism could contribute to obesity and its related metabolic and cardiovascular comorbidities. For instance, mice with targeted overexpression of 11HSD1 in AT exhibit the prototypical features of the MetS with visceral obesity, insulin resistance, diabetes, dyslipidemia, and hypertension (46, 47) . On the contrary, selective inactivation of the glucocorticoid biological effect in AT protects the mice from diet-induced obesity and insulin resistance (38, 53) . Clinical investigations have also suggested that local AT production of glucocorticoids is exacerbated in human obesity and could contribute to the metabolic phenotype (54) . Although it has been considered for a long time that glucocorticoid action in AT was mediated exclusively by the glucocorticoid receptor (GR), more recent works have shown that MR is expressed in white (WAT) and brown AT (BAT) (61, 76) and could mediate pleiotropic effects in these tissues. Thus, it has been reported that MR activation promotes white and brown adipogenesis (8, 9, 45, 57, 76) , modulates adipokine secretion (6, 34) , and inhibits thermogenesis (71) . Moreover, recent studies have demonstrated that MR could mediate proinflammatory events in AT (32) (33) (34) . MR was overexpressed in AT from obese mice (33) , and treatment of genetically obese db/db or ob/ob mice with the selective MR antagonist eplerenone reduced insulin resistance significantly, suppressed macrophage infiltration and reactive oxygen species production in AT, and normalized mRNA levels of obesity-related genes (32, 33) . It has been proposed that the adipocyte MR was involved directly in these proinflammatory properties (32) (33) (34) . Collectively, these results have suggested that MR is a proadipogenic and proinflammatory effector that mediates glucocorticoid and mineralocorticoid hormone's effects on adipocyte development and functions.
To further evaluate the metabolic functions of MR, this study was aimed at examining the in vivo metabolic consequences of human MR (hMR) overexpression in transgenic mice (Tg) generated previously in our laboratory (49) . We subjected male wild-type (WT) and Tg mice to a standard chow (SC) or high-fat diet (HFD). Unexpectedly, Tg mice displayed a reduction in body and fat pad weight associated with an improved glucose tolerance, whereas insulin sensitivity remained unchanged. These alterations in AT development were not explained by an intrinsic loss of preadipocyte differentiation capacities but rather likely involved the proinflammatory properties of the receptor. These results provide new insights into MR involvement in the regulation of energy homeostasis and open new pharmacological strategies for human metabolic disorders with the potential use of selective MR modulators.
MATERIALS AND METHODS
Animals. Eight-week-old previously generated WT and Tg male mice overexpressing hMR (49) were kept on a 12:12-h light-dark cycle in a temperature-controlled colony room with ad libitum access to food and tap water. Mice were challenged for 16 wk with SC (17% fat, 23% protein, and 60% carbohydrates; Harlan, Gannat, France) or HFD (60% fat, 20% protein, and 20% carbohydrates; Research Diets, Gentofte, Denmark). Body weight (BW) was measured weekly. Mice were euthanized, blood samples were collected after intracardiac puncture on heparinized syringes, and tissues were removed, weighted, and used for subsequent gene/protein expression studies, histological and/or fluorescence-activated cell sorting (FACS) analyses, or primary cultures. Mice were bred according to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85-23, revised 1996). The animal facility was granted approval (no. C94 -043-12) by the Ministère de l'Agriculture, France. All procedures were approved by the local ethics committee CAPSud (no. 2012-021).
Metabolic parameter exploration. Oral glucose tolerance test (OGTT) was performed after 16 wk of diet on animals that were fasted overnight for 16 h. Animals were weighed and fed orally using gavage feeding needles (Ref. No. 18060-020; Phymep, Paris, France) with 1 g/kg BW of a 20% glucose solution prepared with tap water. Glucose levels were determined with a glucometer (Accu-Chek Performa; Roche, Bâle, Switzerland) in blood collected from the tail at indicated times. In parallel, blood samples were also collected when possible at basal time for plasma insulin or corticosterone measurements. Collected blood samples were centrifuged at room temperature for 3-5 min at 200 -600 g. Supernatants were collected and stored at Ϫ20°C before subsequent analyses. The area under the curve (AUC) was calculated using the trapezium method.
Insulin tolerance test (ITT) was performed on animals that had been fasted for 4 h. Animals were weighed and injected intraperitoneally with 0.75 U/kg BW of insulin (insulin solution diluted in sterile NaCl solution, Umuline Rapid; Lilly). Glucose levels were determined at indicated times, as described above. Results are expressed as percent of basal glucose levels.
Plasma measurements. Fasting plasma insulin in mice fasted for 16 h was measured using the Ultra Sensitive Insulin ELISA kit (Crystal Chem, Downers Grove, IL). Plasma corticosterone was measured using the AssayMax Corticosterone ELISA Kit (Assaypro, St. Charles, MO). Total cholesterol, HDL cholesterol, triglycerides, and nonesterified fatty acid levels were determined by enzymatic colorimetric assays (Sobodia, Montbonnot-Saint-Martin, France). Leptin level was measured using Bio-Plex Pros Assays (Bio-Rad, Marne-laCoquette, France).
Immunocytochemical and histomorphological procedures. Tissues were fixed overnight in 4% paraformaldehyde in phosphate-buffered saline (PBS), dehydrated in 70% ethanol, and embedded in paraffin. Five-micrometer-thick sections were prepared, permeabilized with 0.1% Triton X-100 diluted in PBS for 10 min at room temperature, and rinsed with PBS. Sections were then incubated in peroxidase blocking solution (3% H 2O2 in PBS) for 30 min to block endogenous peroxidase activity, rinsed with PBS, and incubated with 4% goat serum blocking solution (Impress Reagent Kit; Vectorlabs, Abcys, Les Ulis, France). Sections were subsequently incubated overnight at 4°C with primary antibodies (anti-macrophages; Santa Cruz Biotechnology, Santa Cruz, CA). After washes and incubation of an anti-rat secondary antibody (Impress Reagent Kit) for 1 h at RT, macrophages were detected using AEC Substrate Chromogen (Dako, Trappes, France). Tissue sections were mounted on slides with Glycergel mounting medium (Dako). Immunolabeled sections were examined by two blinded observers on three high-power fields (ϫ20) of one AT section (n ϭ 22 for WT, n ϭ 16 for Tg animals). Relative score labeling was determined as follows: (Ϫ) ϭ negative labeling, (Ϯ) ϭ minimal grade labeling (Ͻ2 positive cells/field), (ϩ) ϭ low-grade labeling (Ͼ5 positive cells/field), (ϩϩ) ϭ medium-grade labeling (Ͼ10 positive cells/field), and (ϩϩϩ) ϭ high-grade labeling (Ͼ20 positive cells/field).
Paraffin-embedded adipose sections were analyzed after hematoxylin and eosin staining. Three fields were observed randomly at ϫ10 magnification of an optical microscope (PROVIS; Olympus, Rungis, France). Adipocyte size quantification was performed using the Image J software (http://rsbweb.nih.gov/ij/) on ϳ500 -800 cells/mouse (6 -12 animals per group and per genotype have been analyzed), leading to a mean adipocyte surface determination on 5,000 -8,000 adipocytes/genotype.
Western blot analysis. Total protein extracts were prepared from inguinal WAT isolated from mice. Briefly, WAT was lysed in lysis buffer (50 mM Tris·HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 30 mM Na pyrophosphate, 50 mM Na fluoride, 1% Triton X-100, and 1ϫ protease inhibitor; Sigma, St. Louis, MO) using a TissueLyser apparatus (Qiagen, Courtaboeuf, France). After protein blotting on an Odyssey nitrocellulose membrane (LI-COR, Lincoln, NE), blots were incubated for 1 h at RT in a blocking buffer (5% fat-free milk in Tris-buffered saline with 0.1% Tween) before overnight incubation at 4°C with a rabbit anti-MR 39N antibody (1:1,000 dilution) and a mouse anti-␣-tubulin antibody (1:5,000 dilution; Sigma-Aldrich, Saint Quentin Fallavier, France). Rabbit polyclonal anti-MR antibody (39N) was generated by use of the human MR 1-18 peptide and purified by affinity chromatography (double X/XP boosting antibody production program; Eurogentec, Seraing, Belgium). After extensive washes, blots were incubated with an IRDye 800-conjugated affinitypurified anti-rabbit IgG second antibody (1:15,000 dilution; Perbio Science, Brebières, France) and an IRDye 680-conjugated affinity purified anti-mouse IgG second antibody (1:15,000 dilution; Perbio Science) for 1 h at room temperature. After washes, proteins were visualized with an Odyssey-Fc apparatus (LI-COR). Specific signals were normalized by the infrared fluorescence of ␣-tubulin signals, as determined by densitometry using the Image Studio software (LI-COR).
Gene expression analysis. Total RNA was extracted from AT, stroma-vascular fractions (SVF), or isolated macrophages with Qiazol reagent (Qiagen, Courtaboeuf, France) or TriReagent (Life Technologies, Villebon sur Yvette, France) according to the manufacturer's recommendations. Total RNA (1 g) was subjected to deoxyribonuclease I amplification Grade treatment (New England Biolabs, Evry, France) and then reverse-transcribed by use of the High-Capacity cDNA reverse transcription kit from Applied Biosystems (Life Technologies, Saint Aubin, France). Samples were diluted 10-fold, after which 1/20 of reverse transcription was used for reverse transcriptionquantitative real time PCR [RT-quantitative PCR (qPCR)] using the Fast SYBR Green Master Mix (Applied Biosystems) containing 300 nM of specific primers. RT-qPCR was carried out on a Step One Plus Real-Time PCR system (Applied Biosystems). Reaction parameters were as follows: 95°C for 20 s and then 40 cycles at 95°C for 1 s and 60°C for 20 s. For preparation of standards, amplicons were purified from agarose gel and subcloned into pGEMT-easy plasmid (Promega, Charbonnières-les-Bains, France) and sequenced to confirm the identity of each sequence. Standard curves were generated using serial dilutions of linearized standard plasmids, spanning six orders of magnitude. Ribosomal 18S was used as an internal control for data normalization. Relative expression of a given gene is expressed as the ratio attomoles of specific gene/picomoles of 18S. Results are means Ϯ SE and generally normalized to the relative expression arbitrarily set at 1 for WT animals.
Isolation of SVF and primary preadipocyte culture. AT from WT and Tg mice was removed, minced into small pieces with scalpel, and then digested with collagenase (0.7 mg/ml in PBS; Sigma-Aldrich) at 37°C, using a shaker for 45 min. Homogenates were passed through a 70-m mesh to remove undigested clumps and debris. The effluent was centrifuged at 100 g for 10 min. Cellular pellets were defined as the SVF and analyzed by FACS or plated on six-well culture dishes. Cells were cultured for 2 days in clonal expansion medium composed of Dulbecco's modified Eagle's medium (DMEM)-high glucose (PAA, Velizy-Villcoublay, France) with penicillin-streptomycine (100 UI/ml) and glutamine (2 mM) (PAA), 10% fetal bovine serum (FBS) (Biowest, Nuaille, France), 0.2% fungizone (Life Technologies, Villacoublay, France), 0.2 nM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), and 200 nM dexamethasone (Sigma-Aldrich). After 2 days, cells were either maintained in DMEM with 10% FBS (control medium) or cultured in adipocyte differentiation medium composed of DMEM and 10% FBS with 100 nM insulin (Sigma-Aldrich), 600 nM rosiglitazone (Sigma-Aldrich), and 2 nM triiodothyronine (SigmaAldrich) for 7 days. Afterward, cells were washed with PBS, and total RNA was extracted as described above.
Flow cytometry analysis and FACS. Spleen, peritoneal fluid, and adipose tissues were collected and rinsed in PBS. Spleen and AT were minced in FACS buffer (PBS with 5% FBS) and passed through a 70-m mesh. SVF were prepared from collagenase-digested adipose tissues, as mentioned above. Extracellular staining was preceded by incubation with purified anti-CD16/32 antibodies (FcgRII/III block, 2.4G2) to block nonspecific staining. Cells were stained with PerCPCy5. Macrophage-conditioned media and primary preadipocyte culture. Adult WT or Tg mice were euthanized, and 5 ml of cold PBS was injected intraperitoneally. After 5 min, peritoneal fluid was collected, and macrophages were recovered by centrifugation. Macrophageconditioned media (CM) were obtained after plating macrophages isolated from WT and Tg mice peritoneal cavity at 2.10 6 cells in six-well plates in 2 ml of RPMI (GE Healthcare, Vélizy-Villacoublay, France) with 10% FBS and 10 ng/ml lipopolysaccharides (LPS; from Salmonella Minnesota Re 595, L9764; Sigma) for 24 h prior to the medium being collected. The CM of macrophages obtained from several individuals per genotype were pooled and stored at Ϫ80°C until use. SVF were prepared from collagenase-digested adipose tissues, as mentioned above. Cells were cultured for 2 days in clonal expansion medium, as described above in 12-well plates. Subsequently, cells were cultured with a 1/10 dilution of CM from either WT or Tg macrophages or with a 1/10 RPMI control medium with adipocyte differentiation medium for 7 days. Afterward, cells were washed with PBS, total RNA was extracted, and gene expression studies were performed as described above.
Statistical analysis. Data, expressed as means Ϯ SE, were analyzed by nonparametric Mann-Whitney test with the use of the computer software Prism 5 (GraphPad Software, San Diego, CA). Comparisons between time points were analyzed using linear regression and distribution of adipocyte surface, and immunolabeling scores were analyzed using contingency test ( 2 ). Values of P Ͻ 0.05 were considered statistically significant.
RESULTS AND DISCUSSION
MR is overexpressed in AT of Tg mice. Given that the hMR was expressed under the control of the proximal promoter of the hMR gene in Tg mice (52), we first examined whether the hMR transgene was expressed in the AT of Tg mice and analyzed the consequences on endogenous murine MR (mMR) expression using species-specific primers for qPCR. As expected, hMR transcripts were readily detected in perirenal AT of Tg mice but not of WT animals (Fig. 1A ). In addition, hMR was also detected in freshly prepared mature adipocytes isolated from AT of Tg mice compared with WT animals (Fig.  1B) , consistent with an adipocyte-targeted hMR overexpression. This was not associated with any substantial modification of mMR transcript levels that were similar in AT of both genotypes (Fig. 1C) .
We next demonstrated by Western blot analysis using the anti-MR 39N antibody raised against the first highly conserved amino acids of the primary MR sequence, thus recognizing both mMR and hMR (69) , that MR protein expression was threefold higher in inguinal AT of Tg mice compared with WT mice (Fig. 1, D and E) . This increase in MR protein level was similar to that observed in cardiomyocytes or neurons derived from hMR-overexpressing embryonic stem cells (50, 55) . These results indicated that MR is indeed overexpressed in Tg mice, notably in AT, irrespective of the site of adipose depots. Altogether, these findings also confirmed that hMR proximal promoter drives transgene expression in AT, thus demonstrating that MR is expressed in all MR target cells where the hMR proximal promoter is active, as anticipated by our previous studies (49) . Finally, our results indicated that Tg mice constitute an appropriate animal model to investigate the functional consequences of global MR overexpression on metabolic balance and energy homeostasis.
Tg mice are protected against HFD-induced obesity.
To examine the metabolic impact of MR overexpression, 8-wk-old WT and Tg male mice were subjected to SC or HFD for 16 wk with measurement of BW at intervals. Compared with WT mice, hMR overexpression resulted in a lower weight gain when mice were maintained under SC (P Ͻ 0.0001; Fig. 2A ). Indeed, WT mice gained 5.5 Ϯ 0.7 g, corresponding to a 23.6% increase in BW, whereas the BW gain of Tg mice (4.0 Ϯ 0.8 g, i.e., 17.8% of BW) was lower compared with WT mice. This difference in BW was not related to a caloric restriction, since we showed previously that Tg mice had a higher food intake than WT animals (51). In addition, there was no difference in either genotype in either the tail-nose distance or the weight of several organs (liver, spleen, heart, kidney, and pancreas) under SC ( Table 1 ). The organ weight/BW ratios did not reveal any significant difference between the two genotypes, and notably, the weight of fat pads was not significantly altered under SC (Table 1) . Thus, global MR overexpression in Tg mice that takes place during early development does not affect organ growth. This finding is in accord with the normal growth observed in MR knockout mice (MR Ϫ/Ϫ ) during development. Indeed, following the initial dehydration related to urinary sodium loss, the slope of growth curve of MR Ϫ/Ϫ mice upon sodium supplementation displays a shape similar to that of controls (5) . Collectively, these observations convey against a major and direct role of MR in the control of body growth and organogenesis.
In an attempt to exacerbate and/or unmask a metabolic phenotype, mice were subjected to a HFD. As expected, 16 wk of ad libitum HFD feeding caused a sharp increase in BW in both genotypes without any difference in the tail-nose distance ( Fig. 2B and Table 1 ). WT mice gained 22.6 Ϯ 2.0 g under HFD. This corresponded to an 86.7% increase in their BW and a fourfold higher weight gain compared with that induced by SC (Fig. 2C ). Under similar experimental conditions, Tg mice had a BW increase of 9.1 Ϯ 1.2 g (Fig. 2B ), corresponding to an increase of 38.4% (Fig. 2C) . Thus, the BW gain observed in Tg mice under HFD was drastically reduced compared with that of WT mice (ϫ2 vs. ϫ4, P Ͻ 0.0001; Fig. 2 , B and C), indicating that MR-overexpressing mice are relatively resistant to HFD-induced obesity.
This marked reduction in BW gain of Tg mice correlated with a decrease in the mass of several fat pads measured at euthanization ( Fig. 3 and Table 1 and Tg mice (n ϭ 5) that were submitted to a 16-wk high-fat diet (HFD) and murine MR (mMR) in perirenal AT from the same animals (C), analyzed by RT-quantitative PCR (qPCR). hMR was expressed only in Tg mice without modification of endogenous MR (mMR) expression. Results are means Ϯ SE, and values measured in Tg mice were arbitrarily set to 1. Relative hMR expression was 7.6 Ϯ 0.9 and 22.1 Ϯ 4.3 amol/pmol 18S in AT and isolated adipocytes, respectively, from Tg mice. MR expression in inguinal AT from WT (n ϭ 10) and Tg mice (n ϭ 11) analyzed by Western blot, using 39N antibody that recognizes both mMR and hMR (D) with quantification of the Western blot bands (E). Results are means Ϯ SE and represent MR/␣-tubulin ratio, arbitrarily set to 1 for WT mice. MR protein expression was 3-fold higher in inguinal AT of Tg mice compared with WT mice. *P Ͻ 0.05; ***P Ͻ 0.001.
animals, Tg mice exhibited decreases of 2.5-, 1.9-, and 3.2-fold in the weight of the perirenal, gonadal, and inguinal adipose depots, respectively (Fig. 3, A and C) . This fat mass reduction in Tg mice was maintained and significant even when the results were normalized to the BW and expressed as AT/BW ratio (44, 29 , and 56% reduction for perirenal, gonadal, and inguinal AT, respectively; Table 1 ). In contrast, owing to the lower BW of Tg mice, some relative organ weight/BW ratios were slightly enhanced (heart, kidney, and pancreas). However, except for white fat depots, none of the absolute or normalized weights of other tissues (BAT, liver, spleen) was decreased in Tg mice under HFD compared with WT mice (Fig. 3D and Table 1 ). Taken together, these results indicate that MR overexpression in Tg mice causes a relative resistance to HFD-induced obesity through specific alteration of WAT development. This phenotype was somehow surprising given the well-described proadipogenic effect of MR in white and brown adipocytes (9, 61, 76 To get further insights into metabolic changes, lipids, glycemia, and insulin plasma levels were measured under basal and dynamic conditions. There was no major difference in circulating total cholesterol and triglycerides between the two genotypes whatever the diet ( Table 1) . As expected, nonesterified fatty acid levels increased drastically upon HFD, but without any difference between WT and Tg mice.
Under SC, leptin level was similar between the two genotypes (Table 1 ). In accord with the HFD-induced adipose weight gain, plasma leptin levels increased markedly in WT mice. However, the induction was strongly reduced in Tg mice, consistent with their lower fat pad mass development.
It is well established that glucocorticoids are the physiological ligands for MR in tissues lacking 11HSD2 activity (24) . In addition, cells harboring 11HSD1 activities, such as hepatocytes and adipocytes, are able to regenerate active glucocorticoids from 11 dehydrometabolites, thus amplifying paracrine actions of these hormones (19) . In this context, the circulating corticosterone levels were determined under SC and HFD challenges. Of note, HFD significantly increases corticosterone levels compared with SC, but without any difference between WT and Tg mice ( Table 1 ). The impact of HFD on the hypothalamus-pituitary-adrenal-axis activity remains rather controversial, and no definite conclusion has been drawn from a recent review of the literature (2). However, whatever the diet and the genotype, basal corticosterone concentrations are sufficient to ensure saturating MR binding and full MR activation in adipose tissues (40) . Thus, we propose that phenotypic alterations observed in Tg mice are related directly to hMR overexpression rather than adaptive modulations of its physiological ligand levels.
To examine whether the marked differences in BW gain and adiposity between the two genotypes were associated with changes in carbohydrate metabolism, we evaluated glycemia and insulinemia under basal (Table 1) ( Fig. 4) . As anticipated, HFD significantly increased fasting glucose levels in both genotypes. However, fasting glycemia was always lower in Tg compared with WT mice (Table 1) . Insulinemia and the HOMA-R, an index of insulin sensitivity, were not different between the two genotypes yet significantly increased, as expected under HFD. Fasting glycemia is essentially dependent on hepatic glucose production through activation of the neoglucogenic pathway (58). However, since MR is not expressed in hepatocytes, it is unlikely that liver MR transgene expression might contribute to the lower fasting plasma glucose measured in Tg mice. In addition, it is well known that insulin strongly inhibits hepatic glucose production, whereas glucagon and corticosterone activate this metabolic pathway. However, a major contribution of these hormones could be excluded since their plasma levels were not significantly different between both genotypes.
We next performed OGTT after 16 h of fasting in animals fed under HFD. As mentioned above (Table 1) , Tg mice exhibited a lower glycemia at baseline compared with WT mice (111.9 Ϯ 12.2 vs. 169.0 Ϯ 11.4 mg/dl, P Ͻ 0.01; Fig.  4A ). After glucose overload (1 g/kg), plasma glucose levels were always lower in Tg mice compared with WT mice at all tested time points (Fig. 4A ). This correlated with a significant decrease in the AUC for Tg mice compared with controls (Fig.  4B) , consistent with an improvement in glucose tolerance.
To further explore the impact of MR overexpression on carbohydrate metabolism, ITT was performed after a 4-h fast. Both Tg and WT animals displayed an apparent similar insulin sensitivity with an equal initial slope, which was indicative of a superimposable glucose uptake or clearance (Fig. 4C) .
These variations in glucose homeostasis call into question their interpretation in an integrative physiological network. The better glucose tolerance observed in Tg mice correlated well with their lower fat mass development under HFD. An excessive adiposity is generally associated with lipid, cytokine, and adipokine profile alterations, which in turn promote lowgrade inflammation and insulin resistance (13, 20, 42) . Unexpectedly, despite their relative resistance to HFD-induced obesity, hMR-overexpressing mice did not improve their insulin sensitivity compared with WT mice. These findings suggested that, in our model, MR-dependent activation does not markedly alter insulin sensitivity. This should be interpreted in the light of previous studies showing that MR blockade by eplerenone reverses insulin resistance in genetically determined obese or diabetic mice (33) and prevents proinflammatory events prevailing in adipose depots (32) . In addition, MR-mediated insulin resistance may be also supported by the higher prevalence of MetS and insulin resistance in patients with primary hyperaldosteronism (22, 23) ; however, this remains controversial (67) . The relative resistance to HFD-induced obesity in hMRoverexpressing mice, which was associated with the lack of insulin sensitivity improvement, prompted us to further investigate properties of adipose depots that represent an essential insulin target and MR-expressing tissue.
Impact of MR overexpression on adipocyte morphology. We first examined AT histology and quantified adipocyte surface in perirenal adipose depots by histomorphological analysis. Three fields of hematoxylin and eosin-stained sections (Fig.  5A ) per animal were analyzed at random, and adipocyte surface was determined using the Image J software (http://rsbweb.nih.gov/ij/) (Fig. 5B) . Thereafter, adipocytes were classified in different categories according to their surface (from 100 to 15,000 m 2 ). As expected, adipocytes of animals fed a HFD were hypertrophic compared with those of mice fed a SC (Fig.  5B, bottom vs. top) . Under SC, 65-70% of adipocytes had a surface Ͻ500 m 2 , whereas they represented only 20% under HFD. Conversely, there were fewer than 3% adipocytes Ͼ2,000 m 2 under SC, whereas cell surface exceeded 2,000 m 2 in Ͼ60% of adipocytes from HFD mice. Of interest, when comparing adipocyte size within the same diet, we observed that MR overexpression influenced adipocyte size distribution. Under SC (Fig. 5B, top) , chi-square analysis on more than 5,000 independent determinations showed that perirenal adipose depots from Tg mice displayed a significantly higher proportion of small adipocytes compared with those of WT mice (P Ͻ 0.0001).
Under HFD (Fig. 5B, bottom) , we observed a very different distribution of adipocyte size of perirenal AT between the two genotypes. Indeed, small adipocytes (Ͻ2,000 m 2 ) were more abundant in Tg mice compared with controls, whereas few large adipocytes (Ͼ7,000 m 2 ) were detected in MR-overexpressing mice. In parallel, there was a significant decrease in the mean adipocyte surface in Tg mice compared with WT mice (3,452 Ϯ 46 vs. 3,703 Ϯ 41 m 2 , respectively; P Ͻ 0.001).
Thus, the higher proportion of small adipocytes in Tg mice could reflect differences in adipocyte development and/or function.
Dysregulation of gene expression in perirenal AT of Tg mice. To determine whether the lower body fat mass and the higher proportion of small adipocytes in Tg mice could be explained by an alteration in adipogenesis, we studied the expression of the transcription factor PPAR␥2 (peroxisome proliferator-activated receptor-␥2), the master adipogenic regulator gene. Under SC, Fig. 6A shows that PPAR␥2 expression was reduced by 40% in the perirenal adipose depot of Tg mice compared with controls. Likewise, under HFD, PPAR␥2 expression remained significantly lower in Tg mice compared with WT animals (147 Ϯ 14 vs. 245 Ϯ 22 amol/pmol 18S A: oral glucose tolerance test (OGTT) performed after 16 wk of HFD in Tg (n ϭ 11) and WT mice (n ϭ 9) subjected to 16 h fasting. After glucose overload (1 g/kg), plasma glucose levels were always lower in Tg mice compared with WT mice at all tested time points. This correlated with a significant decrease in the area under the curve (AUC) for Tg mice compared with controls (B), consistent with an improvement in glucose tolerance. C: insulin tolerance test after 16 wk of HFD in Tg (n ϭ 11) and WT mice (n ϭ 10) subjected to 4 h of fasting. Glycemia were measured at all indicated time points after insulin injection (0.75 U/kg) and expressed as a percentage of basal glycemia. Baseline plasma glucose levels were slightly but significantly lower in Tg mice (135.1 Ϯ 7.5 mg/dl) than in WT mice (177.0 Ϯ 12.8 mg/dl) (P ϭ 0.005). The 2 groups of animals displayed apparent similar insulin sensitivity with an equal initial slope, indicative of a superimposable glucose uptake or clearance. Results are expressed as means Ϯ SE. *P Ͻ 0.05; **P Ͻ 0.01. T0, time zero.
under SC, 68 Ϯ 6 vs. 82 Ϯ 6 amol/pmol 18S under HFD; Fig.  6B ). Similar results were also observed in the inguinal fat depot of Tg mice (data not shown). These findings were in agreement with the disturbed adipocyte development of the Tg fat depot, which was exacerbated by HFD and well correlated with the lower circulating leptin levels (see Table 1 ). However, the downregulation of adipocyte PPAR␥2 expression was in the same order of magnitude in Tg mice, whereas adipose tissue development was drastically reduced under HFD. This suggested that under these conditions, additional events, either cell-autonomous or environmental factors, may be involved in the relative resistance to obesity in Tg compared with WT mice.
To test this hypothesis, we further studied whether hMR overexpression might influence local glucocorticoid signaling, notably GR (Fig. 6, C and D) and 11HSD1 (Fig. 6, E and F) . Surprisingly, Tg mice fed SC displayed a 32% reduction in GR mRNA steady-state levels (Fig. 6C ). This reduction in GR expression in Tg mice was attenuated under HFD, yet it remained significant compared with WT mice (Fig. 6D) , although absolute AT GR expression in WT animals was similar no matter the diet (122 Ϯ 11 vs. 124 Ϯ 8 amol/pmol 18S under SC and HFD, respectively). Likewise, the GR mRNA levels' downregulation was also detected in inguinal AT of Tg mice (data not shown). Of interest, 11HSD1 transcript levels were also decreased significantly in the perirenal AT of Tg mice under SC (Fig. 6E ), but this difference was abolished under HFD (Fig. 6F) depots of mice fed a HFD (43) . Thus, in Tg mice fed a HFD, a complete downregulation of adipocyte 11HSD1 cannot account for decreased local corticosterone regeneration owing to high circulating corticosterone levels. However, we could not exclude that impaired GR activation in Tg animals might affect fat mass development. Collectively, these results suggested that in hMR-overexpressing mice, adaptive regulations in the glucocorticoid signaling pathway may account, at least in part, for resistance to HFD-induced obesity.
In vitro preadipocyte differentiation capacity is not altered by hMR overexpression. Given the apparent discrepancy between the proadipogenic role of MR in preadipocyte cell lines (9, 61, 76) and the partial defect of HFD-induced fat mass development in Tg mice, we examined whether the alteration in adipocyte differentiation was an intrinsic property of hMRoverexpressing preadipocytes. To this aim, SVF were isolated from inguinal, perirenal, and gonadal adipose depots and tested in vitro for their adipogenic capacity (Fig. 7) . As shown in Fig.  7A , freshly isolated SVF of adipose depots were composed of immature undifferentiated preadipocytes (top), which could undergo adipocyte differentiation under appropriate differentiation cocktail exposure for 7 days (bottom). Interestingly, we showed that preadipocytes originated for Tg adipose depots had an identical or even higher adipocyte differentiation ability, as evidenced by appearance of multilocular cytoplasmic lipid droplets compared with WT preadipocytes (Fig. 7A,  bottom) . As expected, this was accompanied by an increased or equivalent PPAR␥2 expression in differentiated adipocytes derived from inguinal, perirenal, or gonadal SVF of Tg compared with WT mice (Fig. 7B) . In addition, adipogenesis is known to be associated with an increased expression of important nuclear receptors, including MR (9, 29) . Accordingly, it was not surprising that mMR expression was induced in hMR-overexpressing adipocytes (Fig. 7C) . Of note, inguinal preadipocytes seemed to exhibit the highest differentiation capacity compared with other perirenal and epididymal adipose depots. Altogether, these results demonstrated that isolated preadipocytes from Tg mice have identical or even enhanced differentiation abilities compared with those from WT animals. In any case, we could exclude that hMR overexpression impairs preadipocyte differentiation commitment. Thus, we propose that relative resistance to HFD-induced obesity in Tg mice is not explained by defective intrinsic adipocyte maturation but rather is due to adipocyte-independent mediators affecting AT development.
Involvement of macrophage polarization in the relative resistance to HFD-induced obesity in Tg mice. Two main arguments led us to focus our attention toward macrophages. On the one hand, obesity is considered to be a chronic lowgrade inflammatory state (7, 72, 75) in which AT itself seems to be a site of inflammation (72), leading to a systemic proinflammatory state, oxidative stress, and insulin resistance (20) . Incidentally, MR and GR exert opposite effects on inflammation and adipocyte differentiation (9, 34) given that MR promotes AT inflammation, whereas GR is an anti-inflammatory factor. Interestingly, obesity is associated with an increased AT accumulation of macrophages that participate in inflammation and contribute to obesity-linked comorbidities (72, 75) . Macrophages can polarize to exert either pro-(M1) or anti-inflammatory (M2) effects, depending on the surrounding tissue microenvironment and the subset of circulating monocyte precursors from which they derive (17) . A phenotypic switch from an M2 to M1 polarized macrophage state has been also described in obesity (41) . On the other hand, MR is expressed in macrophages and seems to be a proinflammatory factor. Administration of MR antagonists reduces macrophage , and 11␤-hydroxysteroid dehydrogenase type 1 (11HSD1) genes (E and F) normalized to 18S rRNA levels was quantified by RT-qPCR in perirenal AT of 6-mo-old male WT (n ϭ 10) and Tg mice (n ϭ 10 -11), both of which were under SC (A, C, and E) and HFD (B, D, and F). PPAR␥2 expression was reduced significantly in Tg animals compared with WT animals, in agreement with a disturbed adipocyte development of Tg fat depot. Tg mice fed a SC displayed a reduction in GR mRNA steady-state levels (C). This reduction of GR expression in Tg mice was attenuated under HFD yet remained significant compared with WT mice (D). 11HSD1 transcript levels were also significantly decreased in the perirenal AT of Tg mice under SC (E), but this difference was abolished under HFD (F). Results are expressed as means Ϯ SE, and values measured in WT mice were arbitrarily set to 1. In WT mice under SC, relative expression of PPAR␥2 was 245.1 Ϯ 22.3 amol/pmol of 18S, of GR was 122.2 Ϯ 11.1 amol/pmol of 18S, and of 11HSD1 was 8.6 Ϯ 1.0 amol/fmol of 18S. Under HFD, in WT animals, relative expression of PPAR␥2 was WT 81.7 Ϯ 6.3 amol/pmol of 18S, of GR was 123.7 Ϯ 8.2 amol/pmol of 18S, and of 11HSD1 was WT 206.8 Ϯ 16.3 amol/pmol of 18S. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, Tg vs. WT animals.
accumulation in a number of disease models (26, 56) , whereas selective macrophage MR deletion protects against mineralocorticoid-mediated cardiac fibrosis despite normal macrophage recruitment (4, 60) . Accordingly, administration of eplerenone, a selective MR antagonist, to genetically obese (ob/ob) and diabetic (db/db) mice decreases their AT inflammation (32, 33) . Furthermore, myeloid-specific MR knockout leads to a transcription profile of alternative macrophage activation (68) and suppresses classically activated M1 macrophage markers while partially preserving alternatively activated M2 markers (28) . These findings suggest that MR activation plays an important role in controlling immune cell function during the inflammatory responses, thereby participating in the metabolic phenotype of our MR-overexpressing mice. This prompted us to examine whether macrophage polarization could account for the relative resistance to HFD-induced obesity.
Immunohistochemistry analysis using an anti-macrophage antibody and semiquantitative scoring of macrophage infiltration in AT (Fig. 8A) did not reveal any significant difference between the two genotypes despite a lower fat pad mass in Tg mice under HFD. However, immunohistochemistry is a semiquantitative and low sensitive method that does not allow precise characterization of the inflammatory profile of the resident and/or infiltrating macrophages. We first confirmed that macrophages purified from spleen by FACS and isolated from peritoneal cavity expressed F4/80 macrophage marker (Fig. 8B, left) , whereas the transgene hMR expression was detected only in macrophages originating from Tg mice, as expected (Fig. 8B, right) . We further investigated macrophage percentage (Fig. 8C, left) by using FACS analysis (see MATE-RIALS AND METHODS). Surprisingly, under SC, Tg mice exhibited a significantly lower proportion of F4/80-positive cells in spleen, a major immune organ (5.1 Ϯ 0.6 vs. 6.7 Ϯ 0.9%, P Ͻ 0.01 compared with WT mice; Fig. 8C, middle) . Similar reduction was detected when either high or intermediate F4/80 subsets were considered independently (data not shown). In HFD animals, a trend toward reduction in splenic macrophage proportion was also observed but was not statistically significant (Fig. 8C, middle) . We next evaluated the proportion of macrophages in AT and found no difference, presumably because of the low proportion of these immune cells in adipose depots and the low fat mass recovered from these animals under SC. However, differences emerged in HFD animals, showing increased proportion of macrophages in SVF isolated from gonadal AT of Tg mice (17.3 Ϯ 1.5 vs. 8.8 Ϯ 0.2% in WT mice, P Ͻ 0.05; Fig. 8C, right) . Collectively, spleen macrophage depletion together with higher AT macrophage infiltration in Tg mice strongly suggested a distinct macrophage distribution between WT and Tg mice, which is consistent with the fact that MR overexpression was associated with a stimulation of macrophage homing in AT, thereby contributing to resistance to HFD-induced obesity.
Macrophage polarization was studied further by FACS, using CD11c antibody as M1 marker and CD206 antibody as (Fig. 8D, left and  middle) . We investigated splenic macrophages, which may represent precursors of tissue macrophages. As shown in 8D, right, Tg mice displayed a distinct macrophage pattern with a trend toward higher M2 differentiation compared with WT cells. In this context, a higher proportion of M2 macrophages in AT may protect from developing obesity. We next performed RT-qPCR analysis in perirenal fat tissues recovered from WT and Tg animals subjected to SC or HFD. Under SC, despite a sharp reduction in F4/80 gene expression in perirenal AT from Tg animals compared with WT (Fig. 8E, left) , CD206 (M2) marker was predominantly expressed, whereas CD11c (M1) was mildly detected (Fig. 8E , right and middle) no matter the genotype. Interestingly, HFD differently affected M1/M2 ratio in WT and Tg animals. As expected, under HFD, F4/80 mRNA levels increased drastically in both genotypes (fold increase was essentially similar), suggesting that macrophage recruitment was induced efficiently in both animals and consistent with chronic low-grade inflammation associated with obesity. However, whereas CD11c mRNA was increased in both WT and Tg animals (reflecting that inflammatory process are equally induced), CD206 mRNA level was reduced in WT but preserved in Tg animals (Fig. 8E) . The higher proportion of macrophages among SVF of Tg animals and the reduced macrophage expression in whole AT could be explained by a lower cellularity of the SVF in Tg animals compared with WT mice. Thus, both FACS and gene expression studies converge to suggest that MR transgene expression promotes a distinct macrophage polarization.
Taken together, these results indicate that macrophage number, infiltration, and polarization are readily affected in MRoverexpressing animals and are very likely dependent upon tissue location (spleen vs. adipose depots) and existing prior diet-induced obesity. This subtle and significant difference in macrophage phenotype is probably underestimated given the complexity of the transition states of macrophage activation, M1 vs. M2, further subdivided in M2a, M2b, and M2c (44), which is finely tuned in response to different microenvironments. This phenomenon is further entangled with the dynamic aspects of the macrophage transition associated with fat mass development. Whether such a distinct macrophage polarization facilitates development of other immune cells such as helper T lymphocytes or modulates natural killer or T regulatory lymphocytes remains to be established (48) . Thus, we propose that MR overexpression in both preadipocytes and mature adipocytes as well as in macrophages leads to distinct modulation of both adaptive and innate immune responses to obesity. Further investigations are needed to better define plasticity and heterogeneity of macrophage phenotype in the context of immunometabolism. Moreover, it would be of interest to examine whether MR overexpression actually modulates the recruitment and infiltration of macrophages within AT or acts preferentially on the population of resident macrophages.
Tg macrophage CM partially impaired preadipocyte differentiation in vitro. To better support the role of hMR overexpression in macrophages on the adipogenesis alteration, we used an ex vivo approach in which CM from either WT or Tg macrophages were tested in vitro for their ability to alter adipogenic capacity of SVF-isolated preadipocytes. CM were prepared by incubating macrophages, which were isolated from the peritoneal cavity of WT (WT CM) and Tg (Tg CM) mice, and activated for 24 h with 10 ng/ml LPS. As anticipated, both WT CM and Tg CM were able to partially inhibit adipocyte differentiation (Fig. 9A) , as evidenced by a significant reduction in PPAR␥2 (Fig. 9B) and FAS (Fig. 9C ) expression in differentiated adipocytes compared with CM (P Ͻ 0.0001 in both conditions). Interestingly, when comparing adipogenic markers among genotypes, PPAR␥2 expression was decreased by 40% with WT CM condition and by 50% with Tg CM condition, yet these values did not reach statistical significance (P ϭ 0.08). However, a significantly higher reduction in FAS mRNA levels was observed after Tg CM exposure (54%) compared with WT CM (47%) (P ϭ 0.015), suggesting that macrophages from MR-overexpressing mice secreted higher amounts of some unidentified cytokines that alter adipocyte differentiation capacity. These important data clearly support the involvement of macrophages in the resistance to high-fat diet-induced obesity. Tg CM had a higher inhibiting effect on preadipocyte differentiation compared with WT CM, indicating that MR overexpression in macrophages could induce a distinct macrophage function that could explain in part AT development alteration. Identification of the Tg macrophage-derived secretory molecules that promote these antiadipogenic properties remains a future challenge. Figure 10 summarizes the main findings of this study. We provided further support for the proadipogenic properties of MR, as evidenced by enhanced adipocyte differentiation capacities of MR-overexpressing preadipocytes ex vivo. However, the relative resistance to HFD-induced obesity observed in Tg mice led us to hypothesize that MR overexpression in innate immune cells and maybe other cell types could alter macrophage polarization, which in turn could impair adipogenesis (10, 31, 37, 39, 65, 66) .
The phenotype observed in our transgenic model is the consequence of global hMR overexpression. We cannot precisely delineate the relative contribution of different cell types in which the MR P1 proximal promoter is functional. However, this transgenic model is relevant to mimic a global, pharmacological, and often non-tissue-selective activation of MR. Clearly, the metabolic phenotype relied not only on specific MR function on adipocytes and macrophages but very likely on other MR target tissues such as endothelial cells or neurons. Despite the complexity of the underlying mechanisms, this model provides a unique opportunity to unravel unexpected MR physiological properties in vivo. Under differentiation cocktail exposure for 7 days, preadipocytes undergo differentiation into mature adipocytes (differentiation medium; top right). The adipocyte differentiation's ability was reduced in the presence of WT and Tg macrophage-CM (WT CM and Tg CM, respectively; bottom). Expression of PPAR␥2 (B) and fatty acid synthase (FAS; C) genes normalized to 18S rRNA levels was quantified by RT-qPCR in preadipocytes, isolated from SVF, and cultured in the presence of WT CM, Tg CM, and RPMI-10% FBS diluted at 1/10 with adipocyte differentiation medium or basal medium. Results are expressed as means Ϯ SE from 3 to 6 independent determinations, and values measured in RPMI-10% FBS diluted at 1/10 with adipocyte differentiation media were arbitrarily set to 1. PPAR␥2 mRNA levels were reduced significantly in CM conditions (WT or Tg) compared with control medium, but there was a trend toward a higher decrease with Tg CM compared with WT CM (P ϭ 0.08). More importantly, FAS expression was reduced by Tg CM (54%) compared with WT CM (47%) (P ϭ 0.015). *P Ͻ 0.05 and ***P Ͻ 0.001 vs. differentiation medium. PPAR␥2 (differentiation medium): 0. 
CONCLUSION
There is now a large body of evidence that corticosteroid effects in AT are mediated by both GR and MR. It was reported that whereas GR mediates an anti-inflammatory response, MR activation promotes a proinflammatory and diabetogenic adipokine expression profile (32) (33) (34) . The balance between gluco-and mineralocorticoid action could play a key role in AT homeostasis and in obesity-and type 2 diabetesassociated metabolic and cardiovascular complications. Thus, selective modulation of GR or MR may offer new avenues for the treatment of insulin resistance and type 2 diabetes. One major challenge would be to dissociate the putative beneficial effects of such drugs from their immunomodulatory properties. Interestingly, a recent work has identified the so-called compound A as a GR-modulating substrate that preserves antiinflammatory properties but has, for instance, no side effects on bone formation (59) . We anticipate that such selective MR modulators could be a relevant strategy in metabolic diseases through an appropriate pharmacological targeting of the proinflammatory properties of MR.
